# Bonum Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bonum-therapeutics

- Industry: Biotechnology
- Headquarters: Seattle, US
- Website: www.bonumtx.com
- Total disclosed funding: $45M
- Latest round: Series A (Nov 15, 2022)
- Investors on record: 6

## About

Based in Seattle, US, and founded in 2021, Bonum Therapeutics, Inc. is a biotechnology company developing protein-based drugs that can sense and respond to their local environment. In December 2021, Bonum Therapeutics, Inc. raised USD 1.19 million in Angel investment from individual investors.

Bonum Therapeutics develops protein-based drugs with regulated, and context-dependent activity with the capability of sensing their local environment and responding accordingly by changing to active form from inactive.

## Funding rounds

- Series A, Nov 15, 2022, $45M — RiverVest Ventures Partners, Vivo Capital, Roche Venture Fund, 503 Partners, Digitalis Ventures, Codon Capital

## Investors

- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series A
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series A
- 503 Partners (https://capitalatlas.ai/funds/503-partners) — Series A
- Digitalis Ventures (https://capitalatlas.ai/funds/digitalis-ventures) — Series A
- Codon Capital (https://capitalatlas.ai/funds/codon-capital) — Series A